**Core Concept**
Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of human immunodeficiency virus (HIV) infection. It works by inhibiting the replication of HIV through binding to the reverse transcriptase enzyme.

**Why the Correct Answer is Right**
Rilpivirine is specifically indicated for the treatment of HIV-1 infection in treatment-naive patients, with a viral load of less than 100,000 copies/mL. This is because the drug requires high viral loads to be effective and is most beneficial in patients with a high viral load. Rilpivirine is also often used in combination with other antiretroviral medications to enhance its efficacy and reduce the risk of drug resistance.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because rilpivirine is not indicated for the treatment of hepatitis B or C. While antiviral medications are used to treat these viral infections, rilpivirine is specifically designed to target HIV.

**Option B:** This option is incorrect because rilpivirine is not used for the treatment of tuberculosis. Antitubercular medications, such as isoniazid and rifampicin, are used to treat TB, but rilpivirine is not one of them.

**Option C:** This option is incorrect because rilpivirine is not indicated for the treatment of viral hemorrhagic fever. While rilpivirine is effective against HIV, it is not used to treat other viral infections like viral hemorrhagic fever.

**Clinical Pearl / High-Yield Fact**
Rilpivirine should be administered with a meal to enhance its bioavailability, as it is a lipophilic drug that requires the presence of fats to be absorbed properly.

**Correct Answer:** C. Treatment of HIV-1 infection in treatment-naive patients.